Shanxi Zhendong Pharmaceutical (300158) — Capital Reinvestment Ratio
Shanxi Zhendong Pharmaceutical (300158) has a Capital Reinvestment Ratio of 14.80x as of June 2024, meaning it reinvests 15% of its operating cash flow (CN¥4.69 Million) in capital expenditures (CN¥69.40 Million). Check Shanxi Zhendong Pharmaceutical tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanxi Zhendong Pharmaceutical Capital Reinvestment Ratio (2007–2022)
This chart tracks Shanxi Zhendong Pharmaceutical's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 300158 cash flow conversion.
Annual Capital Reinvestment Ratio for Shanxi Zhendong Pharmaceutical (2007–2022)
Year-by-year Capital Reinvestment Ratio for Shanxi Zhendong Pharmaceutical from 2007 to 2022. See Shanxi Zhendong Pharmaceutical free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 1.69x | CN¥86.31 Million | CN¥145.81 Million | ▲ +216.9% |
| 2021 | 0.53x | CN¥284.45 Million | CN¥151.66 Million | ▼ -35.7% |
| 2020 | 0.83x | CN¥221.94 Million | CN¥183.96 Million | ▲ +697.6% |
| 2019 | 0.10x | CN¥186.35 Million | CN¥19.37 Million | ▼ -32.9% |
| 2018 | 0.15x | CN¥154.48 Million | CN¥23.92 Million | ▼ -85.4% |
| 2017 | 1.06x | CN¥45.09 Million | CN¥47.93 Million | ▲ +244.1% |
| 2015 | 0.31x | CN¥151.84 Million | CN¥46.92 Million | ▼ -84.3% |
| 2014 | 1.97x | CN¥73.23 Million | CN¥144.15 Million | ▲ +6.9% |
| 2012 | 1.84x | CN¥189.40 Million | CN¥348.75 Million | ▼ -25.5% |
| 2010 | 2.47x | CN¥32.40 Million | CN¥80.09 Million | ▲ +273.1% |
| 2009 | 0.66x | CN¥42.28 Million | CN¥28.01 Million | ▼ -25.1% |
| 2008 | 0.88x | CN¥33.18 Million | CN¥29.35 Million | ▲ +170.4% |
| 2007 | 0.33x | CN¥128.65 Million | CN¥42.07 Million | — |